87 related articles for article (PubMed ID: 32791948)
1. Discharge Prescription Patterns for Antiplatelet Therapy Following Lower Extremity Peripheral Vascular Intervention.
Singh N; Ding L; Magee GA; Shavelle DM; Kashyap VS; Garg PK
Circ Cardiovasc Interv; 2020 Aug; 13(8):e008791. PubMed ID: 32791948
[TBL] [Abstract][Full Text] [Related]
2. Comparative Outcomes of Peripheral Vascular Interventions in Patients on Chronic Anticoagulation with Factor Xa Inhibitors and Vitamin K Antagonists.
Huttler JJ; Alameddine D; Damara FA; Rodriguez PP; Wu Z; Slade M; Strosberg D; Ochoa Chaar CI
Ann Vasc Surg; 2024 Jul; 104():185-195. PubMed ID: 38493886
[TBL] [Abstract][Full Text] [Related]
3. Association of antiplatelet therapy with clinical outcomes in patients with peripheral artery disease.
Al-Sadawi M; Tao M; Dhaliwal S; Masson R; Bhagat AA; Parikh PB; Lawson WE; Reilly JP
Cardiovasc Revasc Med; 2024 May; 62():66-72. PubMed ID: 38176961
[TBL] [Abstract][Full Text] [Related]
4. Determinants and Temporal Trends of Dual Antiplatelet Therapy After Mild Noncardioembolic Stroke.
Del Brutto VJ; Yin R; Gardener H; Ying H; Gutierrez CM; Jameson AM; Rose DZ; Alkhachroum A; Foster D; Dong C; Ancheta S; Sur NB; Gordon Perue G; Rundek T; Asdaghi N; Sacco RL; Romano JG
Stroke; 2023 Oct; 54(10):2552-2561. PubMed ID: 37675611
[TBL] [Abstract][Full Text] [Related]
5. Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study.
Thaarup M; Jacobsen S; Nielsen PB; Nicolajsen CW; Eldrup N; Petersen CN; Behrendt CA; Dahl M; Højen AA; Søgaard M
Eur J Vasc Endovasc Surg; 2024 Jun; 67(6):948-957. PubMed ID: 38341174
[TBL] [Abstract][Full Text] [Related]
6. Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.
Elmariah S; Mauri L; Doros G; Galper BZ; O'Neill KE; Steg PG; Kereiakes DJ; Yeh RW
Lancet; 2015 Feb; 385(9970):792-8. PubMed ID: 25467565
[TBL] [Abstract][Full Text] [Related]
7. Variability patterns in dual antiplatelet therapy following endovascular repair of intracranial aneurysms: Insight into regimen heterogeneity and the need for a consensus.
Wadhwa A; Mensah E; Young M; Ogilvy CS
Acta Neurochir (Wien); 2024 Jun; 166(1):271. PubMed ID: 38888678
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of antiplatelet therapy before endovascular treatment of acute large vessel occlusion: Data from the ANGEL-ACT registry.
Sun D; Li S; Raynald ; Huo X; Jia B; Tong X; Wang A; Ma N; Gao F; Mo D; Nguyen TN; Miao Z;
J Neuroradiol; 2024 Jun; 51(4):101183. PubMed ID: 38346535
[TBL] [Abstract][Full Text] [Related]
9. Platelet function testing and clinical outcomes in peripheral arterial disease: Systematic review and narrative synthesis.
Kankaria A; Majumdar M; Lee S; Hall RP; Suarez Ferreira SP; Lee I; Patel SS; Jessula S; D'Oria M; Dua A
J Vasc Surg; 2024 Jul; 80(1):269-278. PubMed ID: 38122860
[TBL] [Abstract][Full Text] [Related]
10. A multicenter study of DDAVP versus platelet transfusions for antiplatelet agent reversal in patients with traumatic brain injury.
Westfall KM; Andrews J; Sadek E; Curtiss W; Hecht J
Neurol Sci; 2024 Jul; 45(7):3325-3332. PubMed ID: 38353847
[TBL] [Abstract][Full Text] [Related]
11. Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients).
Khan H; Zamzam A; Gallant RC; Syed MH; Rand ML; Ni H; Forbes TL; Al-Omran M; Qadura M
Res Pract Thromb Haemost; 2021 Dec; 5(8):e12618. PubMed ID: 34816074
[TBL] [Abstract][Full Text] [Related]
12. Barriers to Antiplatelet and Statin Adherence Following Major Vascular Intervention.
Nguyen D; D'Andrea M; Joule D; Kulwin J; Rojas C; Zhou W
Ann Vasc Surg; 2024 May; 106():360-368. PubMed ID: 38821476
[TBL] [Abstract][Full Text] [Related]
13. The CLEAR (Considering Leading Experts' Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention.
Wong KHF; Bosanquet DC; Ambler GK; Qureshi MI; Hinchliffe RJ; Twine CP;
CVIR Endovasc; 2019 Nov; 2(1):37. PubMed ID: 32026103
[TBL] [Abstract][Full Text] [Related]
14. 2024 Lower Extremity Peripheral Artery Disease Guideline-at-a-Glance.
Bates KJ; Moore MM; Cibotti-Sun M
J Am Coll Cardiol; 2024 Jun; 83(24):2605-2609. PubMed ID: 38752900
[No Abstract] [Full Text] [Related]
15. Should dual antiplatelet treatment be guided by lipoprotein(a) concentration?
Kubica J
Cardiol J; 2024; 31(2):363-364. PubMed ID: 38686990
[No Abstract] [Full Text] [Related]
16. Direct Evidence for Caution with Single Antiplatelet Therapy Added to Full Dose Anticoagulation for Patients Undergoing Intervention for Lower Extremity Arterial Disease.
Twine CP; Kakkos SK
Eur J Vasc Endovasc Surg; 2024 May; ():. PubMed ID: 38821348
[No Abstract] [Full Text] [Related]
17. Antiplatelet Therapy Following Peripheral Arterial Interventions: The Choice Is Yours.
Aday AW; Gutierrez JA
Circ Cardiovasc Interv; 2020 Aug; 13(8):e009727. PubMed ID: 32791949
[No Abstract] [Full Text] [Related]
18. Antiplatelet and anticoagulation therapy after revascularization for lower extremity artery disease: a national survey and literature overview.
Ipema J; Brand AR; DE Borst GJ; DE Vries JP; ÜnlÜ Ç
J Cardiovasc Surg (Torino); 2021 Feb; 62(1):59-70. PubMed ID: 33112125
[TBL] [Abstract][Full Text] [Related]
19. Prescriber decision-making on antithrombotic therapy after endovascular intervention for peripheral artery disease: a protocol for a discrete choice experiment.
Zhu A; Tang R; Rajendran S; Hajian H; Aitken SJ
BMJ Open; 2024 Mar; 14(3):e079668. PubMed ID: 38508643
[TBL] [Abstract][Full Text] [Related]
20. Oral factor Xa inhibitor underutilization following lower extremity peripheral vascular intervention.
Bhuta S; Ariss RW; Ding L; Nazir S; Magee GA; Garg PK; Gupta R
J Vasc Surg; 2023 Aug; 78(2):498-505.e1. PubMed ID: 37100234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
